Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-06-009761
Filing Date
2006-03-14
Accepted
2006-03-14 13:38:49
Documents
1
Period of Report
2006-03-10

Document Format Files

Seq Description Document Type Size
1 v037636_ex.html 4  
1 v037636_ex.xml 4 12010
  Complete submission text file 0001144204-06-009761.txt   13830
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
WEIS KONRAD M PHD (Reporting) CIK: 0001180753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 06684393